skewed X chromosome inactivation of blood cells is associated with early development of lung cancer in females

• Published in: Oncology reports Vol. 16; no. 4; pp. 859 - 864
• Main Authors: Li, Gang, Su, Qin, Liu, Gui-Qiu, Gong, Li, Zhang, Wei, Zhu, Shao-Jun, Zhang, He-Long, Feng, Ying-Ming
• Format: Journal Article
• Language: English
• Published: Athens S.n. 01.10.2006
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Biological and medical sciences; Case-Control Studies; Child; Chromosomes, Human, X; Dosage Compensation, Genetic; Female; Genetic Predisposition to Disease; Humans; Lung Neoplasms - blood; Lung Neoplasms - genetics; Lung Neoplasms - metabolism; Medical sciences; Middle Aged; Pneumology; Receptors, Androgen - genetics; Tumors; Tumors of the respiratory system and mediastinum; X Chromosome Inactivation; Cell proliferation; Lung disease; Respiratory disease; Lung cancer; Malignant tumor; Inactivation; Carcinogenesis; lung; Blood cell; Cancerology; Gene; Androgen receptor; X chromosome inactivation; Bronchus disease; Female; Genetics; Early; skewed; cancer; X-Chromosome; Hormonal receptor
• ISSN: 1021-335X; 1791-2431
• DOI: 10.3892/or.16.4.859

The skewed X chromosome inactivation (SXCI) was found mainly in adult females. It has been linked to development of ovarian and breast cancers. The present study aimed to describe the relationship between SXCI and development of lung cancer in females. DNA was isolated from blood cells from patients with primary lung cancer (n=148) and reference subjects (n=289). The androgen receptor (AR) gene exon 1 was amplified, with its products from different alleles resolved on denaturing polyacrylamide gels and visualized by silver staining. The corrected ratio (CR) between products from AR alleles after and before HpaII pretreatment was calculated. Occurrence of SXCI was detected in both the patients and reference subjects at similar frequency. However, the phenomenon was more frequent in the patients below 40 years compared to the corresponding reference group, either taking CR >/=3 (25 and 5.8%, respectively; P=0.048) or CR >/=10 as the criterion of SXCI (16.7 and 0.8%, respectively; P=0.022). A higher frequency of SXCI was also found in the patients below 50 years compared to that for the corresponding reference group when CR >/=10 adopted as the criterion (7.9 and 1.2%, respectively; P=0.046). The cancer patients with SXCI were more than 10 years younger in average age than those without SXCI. SXCI of blood cells is associated with early development of lung cancer in females. The X chromosomal inactivation assay, therefore, may be used to screen for females predisposed to malignancies including lung cancer.